Effects of metabolic inhibitors on norepinephrine release from the perfused spleen of the cat.
D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D002415:Cats; D002713:Chlorine / Q000494:pharmacology; D003080:Cold Temperature; D003486:Cyanides / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D000860:Hypoxia; D007461:Iodoacetates / Q000494:pharmacology; D008628:Mercury / Q000494:pharmacology; D009584:Nitrogen / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D010042:Ouabain / Q000494:pharmacology; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D013154:Spleen / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects; D009435:Synaptic Transmission
D001565:Benzoates; D003486:Cyanides; D004140:Dinitrophenols; D007461:Iodoacetates; D013438:Sulfhydryl Compounds; D010643:Phenoxybenzamine; D002713:Chlorine; D010042:Ouabain; D008628:Mercury; D005947:Glucose; D009584:Nitrogen; D011188:Potassium; D009638:Norepinephrine